Alcon Operating Income 2019-2023 | ALC

Alcon annual/quarterly operating income history and growth rate from 2019 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Alcon operating income for the quarter ending December 31, 2023 was $0.208B, a 890.48% increase year-over-year.
  • Alcon operating income for the twelve months ending December 31, 2023 was $1.039B, a 54.61% increase year-over-year.
  • Alcon annual operating income for 2023 was $1.039B, a 54.61% increase from 2022.
  • Alcon annual operating income for 2022 was $0.672B, a 15.86% increase from 2021.
  • Alcon annual operating income for 2021 was $0.58B, a 220.33% decline from 2020.
Alcon Annual Operating Income
(Millions of US $)
2023 $1,039
2022 $672
2021 $580
2020 $-482
2019 $-187
2018 $-248
Alcon Quarterly Operating Income
(Millions of US $)
2023-12-31 $208
2023-09-30 $293
2023-06-30 $270
2023-03-31 $268
2022-12-31 $21
2022-09-30 $205
2022-06-30 $200
2022-03-31 $246
2021-12-31 $182
2021-09-30 $20
2021-06-30 $229
2021-03-31 $149
2020-12-31 $141
2020-09-30 $-129
2020-06-30 $-466
2020-03-31 $-28
2019-12-31 $-68
2019-09-30 $-18
2019-06-30 $-53
2019-03-31 $-48
2018-12-31
2018-09-30 $-284
2018-06-30 $38
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $39.226B $9.455B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $207.950B 25.29
Intuitive Surgical (ISRG) United States $129.849B 78.28
Edwards Lifesciences (EW) United States $51.730B 34.24
DexCom (DXCM) United States $50.391B 86.56
IQVIA Holdings (IQV) United States $41.398B 24.55
IDEXX Laboratories (IDXX) United States $39.563B 47.30
STERIS (STE) Ireland $19.714B 23.33
Hologic (HOLX) United States $17.694B 19.53
Waters (WAT) United States $17.562B 25.20
SONOVA HOLDING (SONVY) Switzerland $16.183B 0.00
ShockWave Medical (SWAV) United States $12.304B 85.01
Fresenius Medical Care AG KGaA (FMS) Germany $11.467B 14.16
Teleflex (TFX) United States $9.729B 15.28
Sysmex ADR (SSMXY) Japan $9.453B 29.64
Penumbra (PEN) United States $7.846B 97.00
Masimo (MASI) United States $7.131B 39.99
Globus Medical (GMED) United States $6.816B 21.61
Glaukos (GKOS) United States $4.843B 0.00
Integer Holdings (ITGR) United States $3.907B 24.97
LivaNova (LIVN) United Kingdom $2.824B 18.62
TransMedics (TMDX) United States $2.753B 0.00
Elekta AB (EKTAY) Sweden $2.581B 17.71
PROCEPT BioRobotics (PRCT) United States $2.558B 0.00
Nihon Kohden (NHNKY) Japan $2.327B 19.68
Integra LifeSciences Holdings (IART) United States $2.254B 9.25
Inari Medical (NARI) United States $2.237B 385.90
Tandem Diabetes Care (TNDM) United States $1.965B 0.00
RxSight (RXST) United States $1.908B 0.00
Alphatec Holdings (ATEC) United States $1.730B 0.00
Veracyte (VCYT) United States $1.460B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.864B 15.99
OPKO Health (OPK) United States $0.857B 0.00
Artivion (AORT) United States $0.825B 95.38
Paragon 28 (FNA) United States $0.812B 0.00
OrthoPediatrics (KIDS) United States $0.721B 0.00
Silk Road Medical (SILK) United States $0.679B 0.00
Treace Medical Concepts (TMCI) United States $0.677B 0.00
SiBone (SIBN) United States $0.633B 0.00
Mesa Laboratories (MLAB) United States $0.543B 18.45
IRadimed (IRMD) United States $0.519B 30.15
ORTHOFIX MEDICAL INC (OFIX) United States $0.490B 0.00
Nevro (NVRO) United States $0.443B 0.00
Pacific Biosciences Of California (PACB) United States $0.415B 0.00
Pulse Biosciences (PLSE) United States $0.397B 0.00
NeuroPace (NPCE) United States $0.367B 0.00
Tactile Systems Technology (TCMD) United States $0.342B 11.52
CVRx (CVRX) United States $0.322B 0.00
AxoGen (AXGN) United States $0.284B 0.00
EDAP TMS S.A (EDAP) France $0.269B 0.00
Sight Sciences (SGHT) United States $0.254B 0.00
AngioDynamics (ANGO) United States $0.251B 0.00
Accuray (ARAY) United States $0.212B 0.00
908 Devices (MASS) United States $0.184B 0.00
Semler Scientific (SMLR) United States $0.181B 9.75
Alpha Tau Medical (DRTS) Israel $0.178B 0.00
Atossa Genetics (ATOS) United States $0.172B 0.00
Inogen (INGN) United States $0.157B 0.00
ClearPoint Neuro (CLPT) United States $0.144B 0.00
Delcath Systems (DCTH) United States $0.124B 0.00
Neuronetics (STIM) United States $0.114B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
Envoy Medical (COCH) United States $0.099B 0.00
KORU Medical Systems (KRMD) United States $0.095B 0.00
Spectral Diagnostics (EDTXF) Canada $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Hyperfine (HYPR) United States $0.060B 0.00
Autonomix Medical (AMIX) United States $0.056B 0.00
Vasomedical (VASO) United States $0.055B 9.83
Sensus Healthcare (SRTS) United States $0.054B 109.67
Vicarious Surgical (RBOT) United States $0.051B 0.00
InspireMD (NSPR) Israel $0.049B 0.00
SEP Acquisition (SEPA) United States $0.049B 0.00
Aspira Women's Health (AWH) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.041B 0.00
Lucid Diagnostics (LUCD) United States $0.038B 0.00
Rapid Micro Biosystems (RPID) United States $0.038B 0.00
Pixie Dust Technologies (PXDT) Japan $0.037B 0.00
LENSAR (LNSR) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.034B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
PAVmed (PAVM) United States $0.017B 0.00
T2 Biosystems (TTOO) United States $0.016B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Microbot Medical (MBOT) United States $0.012B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00